Journal of Sleep Disorders & Therapy
Open Access

Cardiovascular Consequences of Central Sleep Apnea in Congestive Heart Failure Patients

Kimani Ali^{* *}Correspondence: Kimani Ali, Department of Integrative Health and Sleep Sciences, Mount Kenya University, Thika, Kenya, Email:

Author info »

Description

Central Sleep Apnea (CSA) is a complex and multifactorial sleep-related breathing disorder that continues to challenge clinicians and researchers alike due to its intricate pathophysiology and its strong association with other underlying medical conditions. Central sleep apnea typically occurs when the brain’s control over breathing becomes unstable. Under normal physiological circumstances, the respiratory centers located in the brainstem continuously monitor blood levels of carbon dioxide and oxygen. Any elevation in carbon dioxide stimulates an increase in respiratory effort, while a decrease suppresses it. In CSA, this feedback loop becomes dysregulated. The brain either overreacts or underreacts to changes in carbon dioxide levels, resulting in cycles of overbreathing followed by periods of apnea. This instability is often linked to fluctuations in the sensitivity of chemoreceptors that detect changes in blood gases, as well as to altered feedback mechanisms within the central nervous system.

The causes of central sleep apnea are diverse, encompassing both primary (idiopathic) and secondary forms. The primary form occurs without any identifiable underlying condition and is thought to result from inherent instability in the central respiratory control system. Secondary CSA, on the other hand, arises due to medical conditions that affect the brainstem or alter the chemical balance that regulates breathing. One of the most common associations is with congestive heart failure, particularly in cases of Cheyne-Stokes respiration, a form of periodic breathing characterized by cyclical waxing and waning of respiratory effort and tidal volume. This pattern occurs as a consequence of delayed circulation time and an exaggerated response to carbon dioxide changes. Other causes of secondary CSA include stroke, brainstem lesions, chronic opioid use, and high-altitude exposure. The growing use of opioids for chronic pain management has made opioid-induced central sleep apnea an increasingly recognized clinical problem, as these substances depress the respiratory centers in the brain and blunt the normal response to carbon dioxide accumulation.

Central sleep apnea presents a unique diagnostic challenge because its symptoms often overlap with those of obstructive sleep apnea and other sleep disorders. Patients may complain of insomnia, excessive daytime sleepiness, morning headaches or nocturnal awakenings. However, many cases are only detected through polysomnography, a comprehensive sleep study that records brain waves, oxygen levels, heart rate, and breathing patterns. In polysomnographic recordings, CSA is distinguished by the absence of respiratory effort during apnea events, differentiating it from obstructive apneas where breathing effort continues despite airflow cessation. Moreover, central apneas often occur in association with periodic breathing patterns, particularly in patients with heart failure, making detailed interpretation of sleep studies essential for accurate diagnosis.

Neuroimaging and physiological studies have provided valuable insights into the mechanisms underlying CSA. Functional imaging has revealed that certain brain regions responsible for autonomic and respiratory regulation, such as the medulla oblongata and the pons, show altered activity during episodes. In addition, neurochemical studies suggest imbalances in neurotransmitters such as serotonin and acetylcholine, both of which play roles in modulating respiratory drive. In cases related to neurological disease or injury, such as stroke or neurodegenerative disorders, damage to the respiratory centers in the brainstem can directly impair respiratory control, resulting in central apneas. These findings highlight that CSA is not a uniform condition but rather a final common manifestation of various pathophysiological pathways that disrupt the delicate balance between respiratory drive, feedback regulation, and motor execution.